EC Grants Marketing Authorization for Unituxin for Treatment of Paediatric High-Risk Neuroblastoma
August 17, 2015 at 06:03 AM EDT
United Therapeutics Corporation (NASDAQ: UTHR) announced today that the European Commission (EC) has granted Marketing Authorisation for ...